1. Home
  2. HUBC vs ITRM Comparison

HUBC vs ITRM Comparison

Compare HUBC & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBC
  • ITRM
  • Stock Information
  • Founded
  • HUBC 2017
  • ITRM 2015
  • Country
  • HUBC Israel
  • ITRM Ireland
  • Employees
  • HUBC N/A
  • ITRM N/A
  • Industry
  • HUBC
  • ITRM Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUBC
  • ITRM Health Care
  • Exchange
  • HUBC Nasdaq
  • ITRM Nasdaq
  • Market Cap
  • HUBC 35.2M
  • ITRM 40.0M
  • IPO Year
  • HUBC N/A
  • ITRM 2018
  • Fundamental
  • Price
  • HUBC $2.80
  • ITRM $0.71
  • Analyst Decision
  • HUBC
  • ITRM Strong Buy
  • Analyst Count
  • HUBC 0
  • ITRM 2
  • Target Price
  • HUBC N/A
  • ITRM $7.00
  • AVG Volume (30 Days)
  • HUBC 1.1M
  • ITRM 1.0M
  • Earning Date
  • HUBC 05-01-2025
  • ITRM 08-05-2025
  • Dividend Yield
  • HUBC N/A
  • ITRM N/A
  • EPS Growth
  • HUBC N/A
  • ITRM N/A
  • EPS
  • HUBC N/A
  • ITRM N/A
  • Revenue
  • HUBC $29,562,000.00
  • ITRM N/A
  • Revenue This Year
  • HUBC N/A
  • ITRM N/A
  • Revenue Next Year
  • HUBC N/A
  • ITRM $270.19
  • P/E Ratio
  • HUBC N/A
  • ITRM N/A
  • Revenue Growth
  • HUBC N/A
  • ITRM N/A
  • 52 Week Low
  • HUBC $1.72
  • ITRM $0.66
  • 52 Week High
  • HUBC $14.00
  • ITRM $3.02
  • Technical
  • Relative Strength Index (RSI)
  • HUBC 46.20
  • ITRM 29.14
  • Support Level
  • HUBC $2.32
  • ITRM $0.66
  • Resistance Level
  • HUBC $4.33
  • ITRM $0.78
  • Average True Range (ATR)
  • HUBC 0.46
  • ITRM 0.06
  • MACD
  • HUBC -0.19
  • ITRM -0.01
  • Stochastic Oscillator
  • HUBC 30.07
  • ITRM 22.22

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: